253 related articles for article (PubMed ID: 30032440)
1. Metformin protects bone mass in ultra-high-molecular-weight polyethylene particle-induced osteolysis by regulating osteocyte secretion.
Yan Z; Zhu S; Tian X; Ye Z; Zhai D; Zhu Z; Wei D; Zhu Q; Lu Z; Cao X
J Bone Miner Metab; 2019 May; 37(3):399-410. PubMed ID: 30032440
[TBL] [Abstract][Full Text] [Related]
2. MOTS-c inhibits Osteolysis in the Mouse Calvaria by affecting osteocyte-osteoclast crosstalk and inhibiting inflammation.
Yan Z; Zhu S; Wang H; Wang L; Du T; Ye Z; Zhai D; Zhu Z; Tian X; Lu Z; Cao X
Pharmacol Res; 2019 Sep; 147():104381. PubMed ID: 31369811
[TBL] [Abstract][Full Text] [Related]
3. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
[TBL] [Abstract][Full Text] [Related]
4. Evidence that osteocyte perilacunar remodelling contributes to polyethylene wear particle induced osteolysis.
Ormsby RT; Cantley M; Kogawa M; Solomon LB; Haynes DR; Findlay DM; Atkins GJ
Acta Biomater; 2016 Mar; 33():242-51. PubMed ID: 26796208
[TBL] [Abstract][Full Text] [Related]
5. SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis.
Jiao Z; Chai H; Wang S; Sun C; Huang Q; Xu W
J Mol Med (Berl); 2023 May; 101(5):607-620. PubMed ID: 37121919
[TBL] [Abstract][Full Text] [Related]
6. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
Allison H; Holdsworth G; McNamara LM
BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
[TBL] [Abstract][Full Text] [Related]
7. Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling pathway.
Ping Z; Hu X; Wang L; Shi J; Tao Y; Wu X; Hou Z; Guo X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
Acta Biomater; 2017 Mar; 51():513-525. PubMed ID: 28088671
[TBL] [Abstract][Full Text] [Related]
8. Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions.
El Kholy K; Freire M; Chen T; Van Dyke TE
Front Immunol; 2018; 9():1300. PubMed ID: 29946319
[TBL] [Abstract][Full Text] [Related]
9. Effect of fluoride on osteocyte-driven osteoclastic differentiation.
Jiang N; Guo F; Xu W; Zhang Z; Jin H; Shi L; Zhang X; Gao J; Xu H
Toxicology; 2020 Apr; 436():152429. PubMed ID: 32156525
[TBL] [Abstract][Full Text] [Related]
10. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
Amirhosseini M; Madsen RV; Escott KJ; Bostrom MP; Ross FP; Fahlgren A
J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
[TBL] [Abstract][Full Text] [Related]
11. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
[TBL] [Abstract][Full Text] [Related]
12. The Differential Effect of Metformin on Osteocytes, Osteoblasts, and Osteoclasts.
de Vries TJ; Kleemann AS; Jin J; Schoenmaker T
Curr Osteoporos Rep; 2023 Dec; 21(6):743-749. PubMed ID: 37796390
[TBL] [Abstract][Full Text] [Related]
13. Direct effects of osteoprotegerin on human bone cell metabolism.
Grundt A; Grafe IA; Liegibel U; Sommer U; Nawroth P; Kasperk C
Biochem Biophys Res Commun; 2009 Nov; 389(3):550-5. PubMed ID: 19748486
[TBL] [Abstract][Full Text] [Related]
14. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
[TBL] [Abstract][Full Text] [Related]
15. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
Wijenayaka AR; Kogawa M; Lim HP; Bonewald LF; Findlay DM; Atkins GJ
PLoS One; 2011; 6(10):e25900. PubMed ID: 21991382
[TBL] [Abstract][Full Text] [Related]
16. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
17. Osteocytes respond to particles of clinically-relevant conventional and cross-linked polyethylene and metal alloys by up-regulation of resorptive and inflammatory pathways.
Ormsby RT; Solomon LB; Yang D; Crotti TN; Haynes DR; Findlay DM; Atkins GJ
Acta Biomater; 2019 Mar; 87():296-306. PubMed ID: 30690207
[TBL] [Abstract][Full Text] [Related]
18. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
[TBL] [Abstract][Full Text] [Related]
19. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin.
von Knoch F; Heckelei A; Wedemeyer C; Saxler G; Hilken G; Brankamp J; Sterner T; Landgraeber S; Henschke F; Löer F; von Knoch M
J Biomed Mater Res A; 2005 Nov; 75(2):288-94. PubMed ID: 16088891
[TBL] [Abstract][Full Text] [Related]
20. Irradiation-induced osteocyte damage promotes HMGB1-mediated osteoclastogenesis in vitro.
He F; Bai J; Wang J; Zhai J; Tong L; Zhu G
J Cell Physiol; 2019 Aug; 234(10):17314-17325. PubMed ID: 30786022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
